Given however the important role of APP in antitumor responses and the multitude of combinatorial cancer immunotherapy approaches currently under investigation, the modulation of intracellular antigen processing by aminopeptidase inhibitors is highly likely to find an application in enhancing tumor antigenicity. The gene discussed is APP; the disease is neoplasm.